Impact of Nanoliposomes on Hepatitis Virus Pathways: A narrative Review

Hepatitis viruses keep up to remain a significant worldwide health threat owing to their chronic nature, severe hepatic consequences, accompanied withthelimited effectiveness of standard treatments. Nanoliposomes, which are lipid-based nanocarriers, have a lot of potential for improving the administration of antiviral drugs by making them more bioavailable, targeting the liver, and changing how the immune system works. This study intends to focus on the latest developments in the design, physicochemical properties, and processes of nanoliposomes that stop the hepatitis virus from spreading, with an emphasis on the hepatitis B and C viruses. Recent investigations demonstrate their capacity to improve antiviral drug stability, promote hepatic macrophage targeting, and impede viral multiplication,while diminishing systemic toxicity. Additionally, the research article addresses biocompatibility issues, the constraints of existing